|
CDC37L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53389967394446E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85539994479456E-09 |
| Normal-vs-Stage2 |
2.371000E-04 |
| Normal-vs-Stage3 |
1.70609999461391E-08 |
| Normal-vs-Stage4 |
2.4227999606552E-09 |
| Stage1-vs-Stage2 |
8.035800E-01 |
| Stage1-vs-Stage3 |
3.053400E-01 |
| Stage1-vs-Stage4 |
1.909780E-02 |
| Stage2-vs-Stage3 |
3.907600E-01 |
| Stage2-vs-Stage4 |
7.146400E-02 |
| Stage3-vs-Stage4 |
1.817580E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.13180020910875E-10 |
| Normal-vs-AfricanAmerican |
1.696640E-03 |
| Normal-vs-Asian |
2.7763999999042E-07 |
| Caucasian-vs-AfricanAmerican |
5.494400E-01 |
| Caucasian-vs-Asian |
5.825200E-01 |
| AfricanAmerican-vs-Asian |
3.899600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.19669948897661E-10 |
| Normal-vs-Female |
3.33340000047144E-09 |
| Male-vs-Female |
7.949900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.48899999499841E-08 |
| Normal-vs-Age(41-60Yrs) |
5.48869999450474E-08 |
| Normal-vs-Age(61-80Yrs) |
1.89769977509968E-10 |
| Normal-vs-Age(81-100Yrs) |
3.023600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.976200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.704100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.147600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.526400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.075800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.184600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.043800E-01 |
| Classical-VS-Follicular |
5.598400E-01 |
| Classical-VS-Other |
5.998200E-01 |
| Classical-VS-Normal |
5.36940047979328E-10 |
| Tall-VS-Follicular |
1.085780E-01 |
| Tall-VS-Other |
8.865400E-01 |
| Tall-VS-Normal |
1.03600000023185E-07 |
| Follicular-VS-Other |
5.685400E-01 |
| Follicular-VS-Normal |
1.395520E-04 |
| Other-VS-Normal |
8.479200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.66409999616357E-08 |
| Normal-vs-N1 |
1.2135999982732E-09 |
| N0-vs-N1 |
2.405600E-02 |
|
|
